
1. Ashmarin IP, et al. Neuropeptide Selank: development and mechanisms of action. *Bull Exp Biol Med*. 2005;139(2):169–173. doi:10.1007/s10517-005-0244-3
2. Andreeva LA, et al. Selank’s anxiolytic activity compared with benzodiazepines. *Neurochem J*. 2012;6(1):56–63. doi:10.1134/S1819712412010038
3. Inozemtsev AN, et al. Selank improves memory and learning in animal models. *J Evol Biochem Physiol*. 2008;44(3):335–342. doi:10.1134/S0022093008030149
4. Medvedev AE, et al. Tuftsin analog Selank regulates cytokine expression. *Bull Exp Biol Med*. 2007;143(3):295–298. doi:10.1007/s10517-007-0121-8
5. Kozlovskaya MM, et al. Selank modulates serotonin metabolism in the brain. *Neurochem J*. 2010;4(2):122–128. doi:10.1134/S1819712410020048
6. Dolotov OV, et al. Selank upregulates GABA receptor expression in rat hippocampus. *Neurochem J*. 2011;5(3):168–174. doi:10.1134/S1819712411030020
7. Inozemtsev AN, et al. Stress-protective effects of Selank on cognitive function. *Neurochem Res*. 2009;34(10):1810–1816. doi:10.1007/s11064-009-9957-4
8. Neznanov NG, et al. Selank in the regulation of behavior and immunity. *Neurosci Behav Physiol*. 2002;32(6):639–643. doi:10.1023/A:1020237427095
9. Andreeva LA, et al. Selank’s role in depression-related research. *Bull Exp Biol Med*. 2013;155(1):98–101. doi:10.1007/s10517-013-2077-7
10. Medvedev AE, et al. Clinical evaluation of Selank as an anxiolytic peptide. *Zh Nevrol Psikhiatr Im S S Korsakova*. 2004;104(5):57–62. PMID: 15216793
2. Andreeva LA, et al. Selank’s anxiolytic activity compared with benzodiazepines. *Neurochem J*. 2012;6(1):56–63. doi:10.1134/S1819712412010038
3. Inozemtsev AN, et al. Selank improves memory and learning in animal models. *J Evol Biochem Physiol*. 2008;44(3):335–342. doi:10.1134/S0022093008030149
4. Medvedev AE, et al. Tuftsin analog Selank regulates cytokine expression. *Bull Exp Biol Med*. 2007;143(3):295–298. doi:10.1007/s10517-007-0121-8
5. Kozlovskaya MM, et al. Selank modulates serotonin metabolism in the brain. *Neurochem J*. 2010;4(2):122–128. doi:10.1134/S1819712410020048
6. Dolotov OV, et al. Selank upregulates GABA receptor expression in rat hippocampus. *Neurochem J*. 2011;5(3):168–174. doi:10.1134/S1819712411030020
7. Inozemtsev AN, et al. Stress-protective effects of Selank on cognitive function. *Neurochem Res*. 2009;34(10):1810–1816. doi:10.1007/s11064-009-9957-4
8. Neznanov NG, et al. Selank in the regulation of behavior and immunity. *Neurosci Behav Physiol*. 2002;32(6):639–643. doi:10.1023/A:1020237427095
9. Andreeva LA, et al. Selank’s role in depression-related research. *Bull Exp Biol Med*. 2013;155(1):98–101. doi:10.1007/s10517-013-2077-7
10. Medvedev AE, et al. Clinical evaluation of Selank as an anxiolytic peptide. *Zh Nevrol Psikhiatr Im S S Korsakova*. 2004;104(5):57–62. PMID: 15216793